UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.435

Sortiert nach

Failure to Adhere to Protocol Specified Radiation Therapy Guidelines Was Associated With Decreased Survival in RTOG 9704—A Phase III Trial of Adjuvant Chemotherapy and Chemoradiotherapy for Patients With Resected Adenocarcinoma of the Pancreas

International journal of radiation oncology, biology, physics, 2012-02, Vol.82 (2), p.809-816

2012

Volltextzugriff (PDF)

Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704

Journal of clinical oncology, 2008-12, Vol.26 (36), p.5918-5922

2008

Volltextzugriff (PDF)

An iPSC Line from Human Pancreatic Ductal Adenocarcinoma Undergoes Early to Invasive Stages of Pancreatic Cancer Progression

Cell reports (Cambridge), 2013-06, Vol.3 (6), p.2088-2099

2013

Volltextzugriff (PDF)

Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132

Annals of surgical oncology, 2012-04, Vol.19 (4), p.1074-1080

2012

Volltextzugriff (PDF)

Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): Early results of RTOG 0132/ACRIN 6665

Journal of surgical oncology, 2009-01, Vol.99 (1), p.42-47

2009

Volltextzugriff (PDF)

Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer

Clinical cancer research, 2016-12, Vol.22 (24), p.6153-6163

2016

Volltextzugriff (PDF)

The Influence of Total Nodes Examined, Number of Positive Nodes, and Lymph Node Ratio on Survival After Surgical Resection and Adjuvant Chemoradiation for Pancreatic Cancer: A Secondary Analysis of RTOG 9704

International journal of radiation oncology, biology, physics, 2011-12, Vol.81 (5), p.1328-1335

2011

Volltextzugriff (PDF)

Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma

Pancreas, 2008-08, Vol.37 (2), p.154-158

2008

Volltextzugriff (PDF)

Significance of Pathologic Response to Preoperative Therapy in Pancreatic Cancer

Annals of surgical oncology, 2011-12, Vol.18 (13), p.3601-3607

2011

Volltextzugriff (PDF)

Linear Regression Models: Applications in R

Hoffmann, John P.

1st, 2022

Volltextzugriff (PDF)

Full-Dose Gemcitabine With Concurrent Radiation Therapy in Patients With Nonmetastatic Pancreatic Cancer: A Multicenter Phase II Trial

Journal of clinical oncology, 2008-02, Vol.26 (6), p.942-947

2008

Volltextzugriff (PDF)

Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101

JAMA surgery, 2016-08, Vol.151 (8), p.e161137

2016

Volltextzugriff (PDF)

Nonneoplastic celiac axis occlusion in patients undergoing pancreaticoduodenectomy

The American journal of surgery, 2007-03, Vol.193 (3), p.341-344

2007

Volltextzugriff (PDF)

Five Year Results of US Intergroup/RTOG 9704 With Postoperative CA 19-9 ≤90 U/mL and Comparison to the CONKO-001 Trial

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.e291-e297

2012

Volltextzugriff (PDF)

How to Define and Manage Borderline Resectable Pancreatic Cancer

The Surgical clinics of North America, 2013-06, Vol.93 (3), p.663-674

2013

Volltextzugriff (PDF)

The Metastatic/Examined Lymph Node Ratio is an Important Prognostic Factor after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma

The American surgeon, 2004-03, Vol.70 (3), p.235-240

2004

Volltextzugriff (PDF)

Potential prognostic biomarkers of pancreatic cancer

Pancreas, 2014-01, Vol.43 (1), p.22-27

2014

Volltextzugriff (PDF)

Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma

The American journal of surgery, 2008-03, Vol.195 (3), p.318-321

2008

Volltextzugriff (PDF)

RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (3), p.554-560

2016

Volltextzugriff (PDF)

Impact of preoperative therapy on patterns of recurrence in pancreatic cancer

HPB (Oxford, England), 2014-01, Vol.16 (1), p.34-39

2014

Volltextzugriff (PDF)

Matrix-regulated integrin αvβ5 maintains α5β1-dependent desmoplastic traits prognostic of neoplastic recurrence

eLife, 2017-01, Vol.6

2017

Volltextzugriff (PDF)

Partial stomach-partitioning gastrojejunostomy and the success of this procedure in terms of palliation

The American journal of surgery, 2013-09, Vol.206 (3), p.333-339

2013

Volltextzugriff (PDF)

Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the U.S. Intergroup/RTOG 9704 Phase III Trial

Annals of surgical oncology, 2011-05, Vol.18 (5), p.1319-1326

2011

Volltextzugriff (PDF)

Biliary microbiome in pancreatic cancer: alterations with neoadjuvant therapy

HPB (Oxford, England), 2019-12, Vol.21 (12), p.1753-1760

2019

Volltextzugriff (PDF)

Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2008-03, Vol.299 (9), p.1019

2008

Volltextzugriff (PDF)

1 – 25 von 1.435

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.305)
Mit Volltextzugriff
(1.219)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.429)
Japanisch
(237)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Failure to Adhere to Protocol Specified Radiation Therapy Guidelines Was Associated With Decreased Survival in RTOG 9704—A Phase III Trial of Adjuvant Chemotherapy and Chemoradiotherapy for Patients With Resected Adenocarcinoma of the Pancreas

Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704

An iPSC Line from Human Pancreatic Ductal Adenocarcinoma Undergoes Early to Invasive Stages of Pancreatic Cancer Progression

Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132

Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): Early results of RTOG 0132/ACRIN 6665

Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer

The Influence of Total Nodes Examined, Number of Positive Nodes, and Lymph Node Ratio on Survival After Surgical Resection and Adjuvant Chemoradiation for Pancreatic Cancer: A Secondary Analysis of RTOG 9704

Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma

Significance of Pathologic Response to Preoperative Therapy in Pancreatic Cancer

Linear Regression Models: Applications in R

Full-Dose Gemcitabine With Concurrent Radiation Therapy in Patients With Nonmetastatic Pancreatic Cancer: A Multicenter Phase II Trial

Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101

Nonneoplastic celiac axis occlusion in patients undergoing pancreaticoduodenectomy

Five Year Results of US Intergroup/RTOG 9704 With Postoperative CA 19-9 ≤90 U/mL and Comparison to the CONKO-001 Trial

How to Define and Manage Borderline Resectable Pancreatic Cancer

The Metastatic/Examined Lymph Node Ratio is an Important Prognostic Factor after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma

Potential prognostic biomarkers of pancreatic cancer

Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma

RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704

Impact of preoperative therapy on patterns of recurrence in pancreatic cancer

Matrix-regulated integrin αvβ5 maintains α5β1-dependent desmoplastic traits prognostic of neoplastic recurrence

Partial stomach-partitioning gastrojejunostomy and the success of this procedure in terms of palliation

Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the U.S. Intergroup/RTOG 9704 Phase III Trial

Biliary microbiome in pancreatic cancer: alterations with neoadjuvant therapy

Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial

Suchergebnisse filtern